Bixiye
QP24-22 Join the TruHearing Audiology and Hearing Aid Network
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Natiijooyinka Raadinta
Soo bandhiga 2151 - 2160 ee natiijooyinka 4139
Bixiye
QP25-22 Reminder for New to Market Medical Drugs: Medical Drug Evaluation Process List
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP26-22 Provider Directory Validation (PDV) Tool
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP27-22 MHCP Pharmacy Benefit Exclusion for Fyarro
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP28-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit ( QL) Criteria: OpzeluraTM (ruxolitnib)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP29-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TavneosTM (avacopan)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Bixiye
QP30-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: TyrvayaTM (varenicline)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2022
Sheegashooyinka iyo Racfaanada
Blue Cross and Blue Shield of Minnesota Self-Insured Complaint Form
Bixiye
P17-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2022